Advancing Precision Medicine with Companion Diagnostics and Biomarkers https://www.marketsandmarkets.com/Market-Reports/companion-diagnostics-market-155571681.html The global companion diagnostics market is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6% during the forecast period. Growth in this market is mainly driven by factors such as the high drug development activity, structured regulatory framework in the region, large patient pool undergoing advanced medical testing, and policy programs to provide effective care to patients with cancer.